Evidence in favour
- 10 distinct acquisition events survive duplicate and security-type controls.
- Participation spans 7 named insiders rather than one filing source.
Company insider dossier
Cosmos Health Inc. insider intelligence
COSM filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.
87/100
Conviction accumulation
82/100 confidence- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Distribution
- Latest evidence
- 30 Jul 2026
Investment committee read
Conviction accumulation
Priced common-share acquisitions carry more weighted evidence than disposals after freshness, role, size, and duplicate controls.
Research constructive setupsDecision risks
- The latest qualifying filing is more than 30 days old.
Price confirmation map
Weekly price with common-share events
Acquisitions and disposals are aligned to the nearest completed weekly bar.
Mar 2025Sep 2026
Weekly closeCommon-share acquisitionCommon-share disposal
Market confirmation
Price and trend context
- Latest close
- 0.2536 USD
- One-week move
- -7.2%
- Four-week move
- +16.4%
- Fair-value gap
- -63.3%
- Trend signal
- Inactive
- Relative strength
- -51.0
Directional balance
Controlled event mix
100.0%acquisition
- Acquisition events
- 10
- Disposal events
- 0
- Net value
- $1.5M
Cadence
Twelve-week filing pressure
Volume shows attention. Controlled events determine direction.
029 Jun
006 Jul
013 Jul
020 Jul
327 Jul
003 Aug
010 Aug
017 Aug
024 Aug
031 Aug
007 Sep
014 Sep
Named participants
Insider conviction by person
SIOKAS, GRIGORIOSDirector, Chief Executive Officer, 10% Owner815 events
TERZIS, GEORGIOSChief Financial Officer783 events
ASLIDIS, ANASTASIOSDirector721 events
BHUTAWALA, SUHELDirector721 events
DEMETRIADES, DEMETRIOS G.Director, Secretary721 events
HOIDAS, JOHN JAMESDirector721 events
KARKANTZOS, THEODOROS CHRISTOSDirector721 events
Evidence quality
Security and transaction context
Role architecture
Who is participating
Transaction evidence
Auditable COSM filing ledger
Showing 1 to 20 of 20.
SIOKAS, GRIGORIOSDirector, Chief Executive Officer, 10% Owner
AcquisitionCommon equity
349825 sharesCommon Stock, par value $.001
$70.0KDirectional evidence
SIOKAS, GRIGORIOSDirector, Chief Executive Officer, 10% Owner
AcquisitionCommon equity
766284 sharesCommon Stock, par value $.001
$140.0KDirectional evidence
TERZIS, GEORGIOSChief Financial Officer
AcquisitionCommon equity
328407 sharesCommon Stock, par value $.001
$60.0KDirectional evidence
TERZIS, GEORGIOSChief Financial Officer
AcquisitionCommon equity
168135 sharesCommon Stock, par value $.001
$42.0KDirectional evidence
SIOKAS, GRIGORIOSDirector, Chief Executive Officer, 10% Owner
AcquisitionCommon equity
218447 sharesCommon Stock, par value $.001
$45.0KDirectional evidence
SIOKAS, GRIGORIOSDirector, Chief Executive Officer, 10% Owner
AcquisitionCommon equity
701447 sharesCommon Stock, par value $.001
$160.0KDirectional evidence
ASLIDIS, ANASTASIOSDirector
DisposalEquity compensation
40000 sharesRestricted Stock Unit
Not reportedContext evidence
BHUTAWALA, SUHELDirector
DisposalEquity compensation
20000 sharesRestricted Stock Unit
Not reportedContext evidence
DEMETRIADES, DEMETRIOS G.Director, Secretary
DisposalEquity compensation
20000 sharesRestricted Stock Unit
Not reportedContext evidence
HOIDAS, JOHN JAMESDirector
DisposalEquity compensation
20000 sharesRestricted Stock Unit
Not reportedContext evidence
KARKANTZOS, THEODOROS CHRISTOSDirector
DisposalEquity compensation
35000 sharesRestricted Stock Unit
Not reportedContext evidence
SIOKAS, GRIGORIOSDirector, Chief Executive Officer, 10% Owner
DisposalEquity compensation
2350000 sharesRestricted Stock Unit
Not reportedContext evidence
TERZIS, GEORGIOSChief Financial Officer
DisposalEquity compensation
850000 sharesRestricted Stock Unit
Not reportedContext evidence
SIOKAS, GRIGORIOSDirector, Chief Executive Officer, 10% Owner
AcquisitionCommon equity
2350000 sharesCommon Stock, par value $.001
$665.0KDirectional evidence
TERZIS, GEORGIOSChief Financial Officer
AcquisitionCommon equity
850000 sharesCommon Stock, par value $.001
$240.6KDirectional evidence
ASLIDIS, ANASTASIOSDirector
AcquisitionCommon equity
40000 sharesCommon Stock, par value $.001
$11.3KDirectional evidence
BHUTAWALA, SUHELDirector
AcquisitionCommon equity
20000 sharesCommon Stock, par value $.001
$5.7KDirectional evidence
DEMETRIADES, DEMETRIOS G.Director, Secretary
AcquisitionCommon equity
20000 sharesCommon Stock, par value $.001
$5.7KDirectional evidence
HOIDAS, JOHN JAMESDirector
AcquisitionCommon equity
20000 sharesCommon Stock, par value $.001
$5.7KDirectional evidence
KARKANTZOS, THEODOROS CHRISTOSDirector
AcquisitionCommon equity
20000 sharesCommon Stock, par value $.001
$5.7KDirectional evidence
Reading the dossier
Direction and confidence are separate
Conviction
The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.
Confidence
Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.
Disposals
Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.
Price confirmation
The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.
Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.